Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN irritable bowel syndrome with constipation
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Chemistry Professor Michael Nichols discusses Alzheimer’s disease research in latest episode of Inside UMSL podcast
Nichols is investigating proteins linked to inflammation in the brain that occurs as part of the neurodegenerative disease.
MORE IN irritable bowel syndrome with constipation
LATEST NEWS
- Chemistry Professor Michael Nichols discusses Alzheimer’s disease research in latest episode of Inside UMSL podcast
- Inaugural UMSL Engineering Camp helps high school students build excitement about the field
- UMSL names College of Business after accomplished alum and marketing industry leader Ed G. Smith
- College of Education hosts annual Future Teacher Leadership Academy for local high schoolers
- Eye on UMSL: For a good cause
- Art and Design Professor Jeff Sippel named Missouri Arts Council’s Featured Artist for June 2025
- New agreement with Edcor will help UMSL provide educational and career development opportunities to employees across the country
- Johnna Murray, Rachel Thompson and Shawn Murphy receive UMSL Hero Awards
- Joint Engineering Program graduate Kyle Stallings starts platform integration role at Boeing
- Associate Professor Sandra Langeslag kicks off UMSL Lecture Series at City Foundry
